Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+9.86%
-6.83%
+1.36%
-1.12%
-1.93%
AEMD
Aethlon Medical Inc.
$1.58
Chart
$0.37 (+327.03%)
$0.4 (+295.00%)
$0.4 (+295.00%)
$0.45 (+251.11%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.86%
-6.83%
+1.36%
-1.12%
-1.93%
AEMD
Aethlon Medical Inc.
Current Price
$1.58
Login to view Aethlon Medical Inc. (AEMD) recommendation from the last 90 days from financial news and social media.
Chart
$0.37 (+327.03%)
$0.4 (+295.00%)
$0.4 (+295.00%)
$0.45 (+251.11%)
AEMD Latest Analysis
Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26 2025. SAN DIEGO June 20 2025 /PRNewswire/ -- Aethlon Medical Inc. (Nasdaq: AEMD) a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases today announced that it will issue financial results for its fiscal fourth quarter ended...
Today
AEMD: Virtual Meeting With Management Upcoming Presentation of Data in Long Covid. By AEMD CMO will present data on Hemopurifier potential in Long Covid at Keystone Symposium We met virtually with medical therapeutic company Aethlon Medical (NASDAQ:AEMD) this week and present our positive takeaways in this note. AEMD has had an abstract accepted for poster presentation at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes. The companys near-term focus is on assessing i
Thu Jun 12, 2025
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes. Poster Presentation Reviews the Hemopurifier® Affinity Resins Ability to Bind Extracellular Vesicles in Long COVID Samples SAN DIEGO June 9 2025 /PRNewswire/ -- Aethlon Medical Inc. (Nasdaq: AEMD) a medical therapeutic company focused on developing products to treat cancer and...
Mon Jun 9, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AEMD Stock trends
AEMD Stock performance
AEMD Stock analysis
AEMD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
